Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management
Recruiting
N/A
Interventional Study
Venous Thromboembolic Event
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 25 (estimated)
- Sponsor
- Ain Shams University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Adults (≥21 years) admitted to the burn unit with thermal burns ≥20% TBSA and \< 60%.
2. Admission to BICU within 48 hours of burn injury.
3. Indication for VTE prophylaxis (e.g., immobilized, surgical intervention).
4. Ability to provide informed consent
Exclusion Criteria:…
Contacts